{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:54:37Z","timestamp":1793321677287,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2017-00369"],"award-info":[{"award-number":["2017-00369"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-935632"],"award-info":[{"award-number":["SLS-935632"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-786651"],"award-info":[{"award-number":["SLS-786651"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009556","name":"Systembolaget Aktiebolag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003945","name":"Link\u00f6pings Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009802","name":"Soderstrom Konigska Hospital Foundation","doi-asserted-by":"publisher","award":["SLS-940846"],"award-info":[{"award-number":["SLS-940846"]}],"id":[{"id":"10.13039\/501100009802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","award":["FO2020-0220"],"award-info":[{"award-number":["FO2020-0220"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","award":["FO2018-0256"],"award-info":[{"award-number":["FO2018-0256"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","award":["FO2022-0295"],"award-info":[{"award-number":["FO2022-0295"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009535","name":"Systembolaget AB","doi-asserted-by":"publisher","award":["2017-0087"],"award-info":[{"award-number":["2017-0087"]}],"id":[{"id":"10.13039\/501100009535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009535","name":"Systembolaget AB","doi-asserted-by":"publisher","award":["2018-0079"],"award-info":[{"award-number":["2018-0079"]}],"id":[{"id":"10.13039\/501100009535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009535","name":"Systembolaget AB","doi-asserted-by":"publisher","award":["2022-0026"],"award-info":[{"award-number":["2022-0026"]}],"id":[{"id":"10.13039\/501100009535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["75320"],"award-info":[{"award-number":["75320"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["2020-01428"],"award-info":[{"award-number":["2020-01428"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.lanepe.2025.101310","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:55:40Z","timestamp":1747122940000},"page":"101310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9434-6878","authenticated-orcid":false,"given":"Bo","family":"S\u00f6derpalm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Lid\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4355-1967","authenticated-orcid":false,"given":"Johan","family":"Franck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Heilig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joar","family":"Guterstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Samuelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Askerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Wallmark-Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Bejczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2025.101310_bib2","series-title":"The socioeconomic consequences of alcohol. A descriptive socioeconomic study.","year":"2020"},{"key":"10.1016\/j.lanepe.2025.101310_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881113512038","article-title":"Doing it by numbers: a simple approach to reducing the harms of alcohol","volume":"28","author":"Nutt","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.lanepe.2025.101310_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/alcalc\/agp096","article-title":"Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and non-abstinence groups","volume":"45","author":"Heather","year":"2010","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.lanepe.2025.101310_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172889","article-title":"Novel medications for problematic alcohol use","volume":"134","author":"Heilig","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.lanepe.2025.101310_bib6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1530-0277.2011.01523.x","article-title":"The efficacy of disulfiram for the treatment of alcohol use disorder","volume":"35","author":"J\u00f8rgensen","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lanepe.2025.101310_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.lanepe.2025.101310_bib8","first-page":"858","article-title":"The treatment gap in mental health care","volume":"82","author":"Kohn","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanepe.2025.101310_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.lanepe.2025.101310_bib10","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1523\/JNEUROSCI.16-10-03474.1996","article-title":"Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats","volume":"16","author":"Weiss","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.lanepe.2025.101310_bib11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1176\/appi.ajp.162.8.1515","article-title":"Correlation of alcohol craving with striatal dopamine synthesis capacity and D2\/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients","volume":"162","author":"Heinz","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.lanepe.2025.101310_bib12","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1523\/JNEUROSCI.3371-07.2007","article-title":"Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement","volume":"27","author":"Volkow","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.lanepe.2025.101310_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/alcalc\/36.4.329","article-title":"Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study","volume":"36","author":"Wiesbeck","year":"2001","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.lanepe.2025.101310_bib14","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.lanepe.2025.101310_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"J Addict Med"},{"key":"10.1016\/j.lanepe.2025.101310_bib16","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial","volume":"39","author":"de Bejczy","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lanepe.2025.101310_bib17","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/acer.12883","article-title":"Phosphatidylethanol is superior to carbohydrate-deficient transferrin and \u03b3-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level","volume":"39","author":"Walther","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lanepe.2025.101310_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12807","article-title":"Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats","volume":"25","author":"Soderpalm","year":"2020","journal-title":"Addict Biol"},{"key":"10.1016\/j.lanepe.2025.101310_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s007020070068","article-title":"Pharmacological validation of a new animal model of alcoholism","volume":"107","author":"Spanagel","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.lanepe.2025.101310_bib20","series-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","first-page":"41","article-title":"Timeline follow-back: a technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"key":"10.1016\/j.lanepe.2025.101310_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296118","article-title":"A randomized, double-blind, placebo-controlled, multicentre trial on the efficacy of varenicline and bupropion in combination and alone for treatment of alcohol use disorder: protocol for the COMB study","volume":"19","author":"de Bejczy","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.lanepe.2025.101310_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-642-28720-6_170","article-title":"Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points","volume":"13","author":"S\u00f6derpalm","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.lanepe.2025.101310_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2016.09.021","article-title":"The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors","volume":"113","author":"Pandhare","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lanepe.2025.101310_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.111.185306","article-title":"Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor","volume":"339","author":"Lummis","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lanepe.2025.101310_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.lanepe.2025.101310_bib26","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1111\/bph.12690","article-title":"Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens","volume":"171","author":"Feduccia","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lanepe.2025.101310_bib27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/adb.12645","article-title":"Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level","volume":"23","author":"van den Brink","year":"2018","journal-title":"Addict Biol"},{"key":"10.1016\/j.lanepe.2025.101310_bib28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","article-title":"In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography","volume":"54","author":"Learned-Coughlin","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.lanepe.2025.101310_bib29","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2174\/138161211796150837","article-title":"Pharmacotherapy for smoking cessation: present and future","volume":"17","author":"Aubin","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.lanepe.2025.101310_bib30","series-title":"The Swedish council for information on alcohol and other drugs (CAN)","article-title":"Tobacco and nicotine development in Sweden 2023","author":"Zetterqvist","year":"2023"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225001024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225001024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:20:33Z","timestamp":1778923233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776225001024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"alternative-id":["S2666776225001024"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101310","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101310"}}